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Inhibition of type 1 ﬁmbriae-mediated Escherichia
coli adhesion and bioﬁlm formation by trimeric
cluster thiomannosides conjugated to diamond
nanoparticles†
Manakamana Khanal,‡a Fanny Larsonneur,‡b,c Victoriia Raks,d,e Alexandre Barras,a
Jean-Sébastien Baumann,f Fernando Ariel Martin,b Rabah Boukherroub,a
Jean-Marc Ghigo,b Carmen Ortiz Mellet,e Vladimir Zaitsev,e,g
Jose M. Garcia Fernandez,h Christophe Beloin,*b Aloysius Siriwardena*f and
Sabine Szunerits*a
Recent advances in nanotechnology have seen the development of a number of microbiocidal and/or
anti-adhesive nanoparticles displaying activity against bioﬁlms. In this work, trimeric thiomannoside clus-
ters conjugated to nanodiamond particles (ND) were targeted for investigation. NDs have attracted atten-
tion as a biocompatible nanomaterial and we were curious to see whether the high mannose glycotope
density obtained upon grouping monosaccharide units in triads might lead to the corresponding ND-
conjugates behaving as eﬀective inhibitors of E. coli type 1 ﬁmbriae-mediated adhesion as well as of
bioﬁlm formation. The required trimeric thiosugar clusters were obtained through a convenient thiol–ene
“click” strategy and were subsequently conjugated to alkynyl-functionalized NDs using a Cu(I)-catalysed
“click” reaction. We demonstrated that the tri-thiomannoside cluster-conjugated NDs (ND-Man3) show
potent inhibition of type 1 ﬁmbriae-mediated E. coli adhesion to yeast and T24 bladder cells as well as of
bioﬁlm formation. The bioﬁlm disrupting eﬀects demonstrated here have only rarely been reported in the
past for analogues featuring such simple glycosidic motifs. Moreover, the ﬁnding that the tri-thiomanno-
side cluster (Man3N3) is itself a relatively eﬃcient inhibitor, even when not conjugated to any ND ediﬁce,
suggests that alternative mono- or multivalent sugar-derived analogues might also be usefully explored
for E. coli-mediated bioﬁlm disrupting properties.
1. Introduction
Bacterial infectious diseases pose a major threat to human
health. Several share clinical characteristics such as chronic
inflammation and tissue damage, and are greatly exacerbated
when microorganisms grow as biofilms on mucosal surfaces
or medical devices.1,2 Biofilms enable the bacteria residing
within them to counter and resist the action of the human
immune system and to enhance their tolerance towards
antibiotics, leading to infections that are very diﬃcult to
eradicate.3–5 The threat of biofilm-related infections has been
greatly aggravated with the emergence of multidrug resistant
bacteria, a phenomenon that has been compounded in the
past decades with the overuse and misuse of antibiotics. These
and other considerations have generated an increased interest
in the development of non-biocidal anti-infective strategies as
alternatives to antibiotics, as these would be expected to show
reduced tendency to provoke the appearance of resistant
strains.6–13 One such approach is the development of a
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number of microbiocidal and/or anti-adhesive nanoparticles
displaying activity against biofilms.14–19 Among the targets
that have been identified for anti-adhesive nanoparticles are
type 1 fimbriae, which constitute major virulence factors pro-
duced by Escherichia coli (E. coli).20 Type 1 fimbriae are fila-
mentous tubular structures each of 0.2–2.0 µm in length and
5–7 nm in diameter that are distributed over the entire surface
of the bacterium.21 In various E. coli strains the lectin located
at the extremity of type 1 fimbriae, FimH, contributes to tissue
colonization through its specific recognition of the terminal
α-D-mannopyranosyl units present on cell-surface glyco-
proteins. FimH-mediated adhesion to such mannosyl moieties
has been demonstrated to be crucial for the interaction of
E. coli with uroplakins and consequently for bladder coloniza-
tion.22 Disruption of this interaction has been proposed as a
promising strategy for the development of an anti-adhesive
therapy.23,24
While a number of multivalent as well as monovalent
sugar-based ligands have been reported to show promise
as eﬀective inhibitors of E. coli adhesion to eukaryotic
cells,9,20,25–31 multivalent presentation of carbohydrate ligands
on appropriate scaﬀolds has been demonstrated, in several
instances, to lead to significantly increased aﬃnities for their
appropriate lectin target compared to a monovalent
ligand.32–37 These avidities can be dramatically superior
to those arising from a simple additive eﬀect. The types of
multivalent structures targeting FimH thus far reported
are very varied and range from small- to medium-sized
scaﬀolds presenting carbohydrate-derived ligands, to larger
entities such as sugar-decorated polymers and nanoparticles,
and a multitude of creatively designed compounds in
between.20,38,39
We and others have been interested in exploring whether
the reported characteristic properties of nanodiamonds (NDs)
might be taken advantage of in the development of useful
inhibitors of type 1 fimbriae-mediated E. coli adhesion.40–42,72
ND particles are completely inert, optically transparent, bio-
compatible and moreover, easily functionalizable via a variety
of strategies depending on their intended application.43–50
Although their in vivo toxicity depends in particular on their
surface characteristics (as well as the nature of the ligands they
carry on their surface),51 ND particles have thus far been
reported not to induce significant cytotoxicity in a variety
of cell types.51–54 The demonstration that our 1st-generation
sugar-conjugated NDs do show marked anti-adhesive activity
in cell-based assays without displaying toxicity against eukary-
otic cells conforted us in our choice of particle and convinced
us that sugar-NDs should indeed be further pursued as bio-
materials. Particularly striking was the unexpected observation
that these ND-mannose conjugates are able to inhibit E. coli-
induced biofilm formation. Such a feature has indeed only
been observed rarely for ligands of FimH but would be
expected to constitute a very desirable additional attribute in
any potential anti-adhesive molecule.9,40,55 Moreover, anti-
biofilm disrupting activity had not apparently been described
previously for alternative glyco-nanoparticles (glyco-NPs) such
as glycofullerenes, gold-based glyco-NPs or for other multi-
valent mannose-derived molecules.33,36,41
The coupling strategy used for the fabrication of our 1st-
generation glyco-NDs was selected with the expectation that it
would ensure not only a convenient means of conjugating
carbohydrate moieties to the ND core, but also provide a linker
that would itself constitute an extended ligand for FimH. In
that approach propargyl sugar derivatives were ligated using a
Cu(I)-catalysed Huisgen cycloaddition reaction (“click” reac-
tion) to NDs decorated with surface azidophenyl functions. To
further scrutinize the origin of the bacterial adhesion and
biofilm growth inhibition activities observed for our 1st-gene-
ration glyco-NDs, we embarked on the investigation of a
second, structurally complimentary, family of sugar-conju-
gated NDs. It was decided that the 2nd-generation ND-sugar
conjugates were to be obtained through an alternative sugar-
conjugation strategy and, in addition, would feature a trimeric
thiomannoside cluster motif as a contrasting mode of surface-
sugar presentation. Indeed various O-glycoside-derived
trimeric clusters have been shown to be strong ligands for
FimH compared with their corresponding monovalent ana-
logues.20,28 Moreover, it has been demonstrated that trimeric
mannoside and thiomannoside clusters, related to those pro-
posed, often give relatively large multivalent eﬀects towards
mannose-specific lectins.56–60 The sugar-linker of our 2nd-gene-
ration ND-sugar conjugates is quite diﬀerent from the one fea-
tured in the 1st-generation NDs, (synthesized through the
“clicking” of propargyl glycosides to ND-grafted azido func-
tions) and would thus very probably make diﬀerent secondary
interactions with the sugar-binding pocket in FimH. Further-
more, the trimeric thiosugar cluster backbone would be
expected to be relatively flexible and, in addition, its peripheral
thiomannosyl moieties held much further away from the ND
surface than the mannosyl units featured in the 1st-generation
NDs. Taken together, we suspected that all these factors would
serve to render the sugar moieties present in the targeted 2nd-
generation ND-conjugates more accessible to FimH receptors
on the bacterial surface than those featured in our 1st-gene-
ration conjugates and thus give contrasting behavior in the
projected biological assays.
An additional feature of the second family of glyco-NDs pro-
posed in this work is the installation of thioglycoside linkages
which would render the anomeric tethering function much
more robust to acidic or enzymatic hydrolysis than the O-glyco-
sidic functions featured in our initial ND-sugar conjugates.
This strategy has been a design feature of a multitude of thio-
glycoside-based ligands61 and we were surprised to discover
that such a functional group motif had rarely been integrated
into potential inhibitors of FimH and FimH-mediated E. coli
adhesion events. Yet another diﬀerence between the 1st- and
targeted 2nd-generation sugar-NDs is that the concentration of
surface triazole functions relative to that of conjugated manno-
syl moieties in the later family would be much lower than in
the original ND sugar-conjugates. We were curious to ascertain
if inhibition of type 1 fimbriae-mediated adhesion might in
some way be connected to: (i) the presence and accessibility of
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surface triazole functions; (ii) to the presence of multiple
surface-conjugated mannosyl units; (iii) to the inherent
physico-chemical characteristics of the ND core itself, or even
to some combination of the three.
We show in this paper the successful integration of trimeric
thiomannosyl clusters onto alkynyl-terminated NDs, to give
the targeted 2nd-generation sugar-conjugated NDs (ND-Man3)
(Fig. 1). Thiolactoside trimer-ND conjugates (ND-Lac3) and
ND-OH particles have also been prepared as negative controls.
These compounds have all been tested as inhibitors of E. coli
adhesion to yeast and also to T24 bladder cells. The thio-
mannosyl trimer-NDs (ND-Man3), but not the negative con-
trols, have been found to be strong inhibitors of both E. coli
adhesions in both assays. In addition, these ND-Man3 particles
are shown also to inhibit E. coli-driven biofilm growth
significantly.
2. Experimental
2.1. Materials
Reagents and solvents were purchased from commercial
sources and used without further purification. Azo-bis(iso-
butyronitrile), dichloromethane, trifluoromethanesulfonic anhy-
dride, pyridine, and N,N-dimethylformamide are indicated by
the acronyms AIBN, DCM, Tf2O, Py, and DMF, respectively.
Fig. 1 Schematic illustration of the stepwise chemical functionalization of diamond nanoparticles (ND) to give the target ND-conjugated trimeric
thiosugar clusters (2nd-generation ND). For comparison, the structure of the 1st-generation ND (ND-mannose)40 is presented.
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Thin-layer chromatography (TLC) was carried out on alumi-
num sheets coated with Kieselgel 60 F254, with visualization
by UV light and by charring with 10% H2SO4 or 0.2% ninhy-
drin. Column chromatography was carried out on silica gel 60
(230–400 mesh).
2.2. Synthesis of tri-thiomannoside (Man3N3) and tri-
thiolactoside (Lac3N3) cluster ligands for ND conjugation
The synthesis of the new trivalent clusters (Man3N3) and
(Lac3N3) (Fig. 2) was achieved following a four-step reaction
sequence involving: (i) radical addition of the corresponding
per-O-acetyl-1-thiosugar B or C to tri-O-allylpentaerythritol A,
using either UV (250 nm) light in DCM (for B; room tempera-
ture, 1 h) or AIBN in dioxane (for C; 75 °C, 3 h) as radical
initiator; (ii) activation of the focal hydroxyl group in the
resulting adducts by triflation with Tf2O-Py in DCM (−25 °C,
40 min); (iii) nucleophlic displacement of triflate by azide ion
by reaction of the crude triflic esters with NaN3 in DMF (room
temperature, 3 h; 73 and 50% yield over three steps for the pre-
viously reported per-O-acetylated azide-armed trimannoside
D62 and trilactoside E,63 respectively); and (iv) final catalytic
deacetylation with sodium methylate in dry methanol as
detailed below. The precursor triallylated pentaerythritol
derivative A (Fig. 2) required for the synthesis of Man3N3 and
Lac3N3 was prepared following the reported procedure.
64
2,3,4,6-tetra-O-acetyl-1-thio-α-D-mannopyranose (B) and
2,3,6,2′,3′,4′,6′-hepta-O-acetyl-1-thio-β-lactose (C) were prepared
from the corresponding sugar per-O-acetates in three steps:
transformation into the corresponding glycosyl halides, treat-
ment with thiourea, and subsequent hydrolysis of the resulting
isothiouronium salt with potassium metabisulfite (K2S2O5)
(Fig. 2).65,66 Full spectral data are reported in ESI (Fig. S2–S5†).
2.2.1. 2,2,2-Tris[5-(α-D-mannopyranosylthio)-2-oxapentyl]-
ethyl azide (Man3N3). To a solution of 2,2,2-tris[5-(2,3,4,6-O-
tetra-acetyl-α-D-mannopyranosylthio)-2-oxapentyl]ethyl azide
(D) (294 mg, 0.214 mmol) in dry MeOH (20 mL) was added
methanolic MeONa (1 M, 0.1 equiv. per mol of acetate). The
reaction mixture was stirred at room temperature for 30 min,
then neutralized with Amberlite IRA-120 (H+) ion-exchange
resin, concentrated, and the resulting residue was freeze-dried
to aﬀord Man3N3 (189 mg, quant.) as a white solid. [α]D +154.3
(c 0.56, H2O). Rf 0.19 (10 : 20 : 1 CH3CN–H2O–NH4OH).
Fig. 2 Synthetic routes to tri-thiomannoside Man3N3 and tri-thiolactoside Lac3N3 clusters.
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1H NMR (500 MHz, CD3OD) δ 5.23 (bs, 3 H, H-1Man), 3.92 (bs,
3 H, H-2Man), 3.89 (ddd, 3 H, J4,5 = 11.9 Hz, J5,6b = 5.6 Hz, J5,6a
= 2.4 Hz, H-5Man), 3.81 (dd, 3 H, J6a,6b = 11.9 Hz, H-6aMan), 3.
(dd, 3 H, H-6bMan), 3.66 (m, 6 H, H-3Man, H-4Man), 3.51 (t, 6 H,
3JH,H = 6.0 Hz, H-3Pent), 3.33 (t, 2 H,
3JH,H = 7.0 Hz, CH2N3),
3.33 (m, 6 H, H-1Pent), 2.72 (m, 6 H, H-5Pent), 1.88 (m, 6 H,
3JH,
H = 6.6 Hz, H-4Pent).
13C NMR (125.7 MHz, CD3OD) δ 86.5
(C-1Man), 74.9 (C-5Man), 73.7 (C-2Man), 73.2 (C-3Man), 70.8
(C-3Pent), 70.6 (C-1Pent), 68.9 (C-4Man), 62.7 (C-6Man), 53.1
(CH2N3), 44.7 (Cq) 30.8 (C-4Pent), 28.8 (C-5Pent). ESIMS: m/z
892.4 [M + Na]+. Anal. Calcd for C32H59N3O18S3: C, 44.18; H,
6.84; N, 4.83; S, 11.06. Found: C, 43.6; H, 6.66; N, 4.51; S,
10.79.
2.2.2. 2,2,2-Tris[5-(β-lactosylthio)-2-oxapentyl]ethyl azide
(Lac3N3). To a solution of 2,2,2-tris[5-(2,3,6,2′,3′,4′,6′-hepta-O-
acetyl-β-lactosylthio)-2-oxapentyl]ethyl azide (E) (294 mg,
0.131 mmol) in dry MeOH (20 mL) was added methanolic
MeONa (1 M, 0.1 equiv. per mol of acetate). The reaction
mixture was stirred at 40 °C for 45 min, then neutralized with
Amberlite IRA-120 (H+) ion-exchange resin, concentrated, and
the resulting residue was freeze-dried to aﬀord Lac3N3.
(180 mg, quant.) as a white solid. [α]D −7.4 (c 0.60, H2O). Rf
0.17 (6 : 3 : 1 CH3CN–H2O–NH4OH).
1H NMR (500 MHz, D2O):
δ 4.42 (m, 6 H, H-1Lact, H-1′Lact), 4.00–3.30 (m, 54 H, H-2Lact to
H-6a,bLact, H-2′Lact to H-6′a,bLact, H-1Pent, H-3Pent and CH2N3),
2.81 (2 dt, 6 H, J4′,5′ = 7.0 Hz, J5a′,5b′ = 14.0 Hz, H-5Pent), 1.91 (m,
6 H, H-4Pent);
13C NMR (125.7 MHz, CD3OD) δ 105.1 (C-1′Lact),
87.2 (C-1Lact), 80.7 (C-5Lact), 80.5 (C-4Lact), 77.9 (C-3Lact),
77.1 (C-5′Lact), 74.9 (C-3′Lact), 74.1 (C-2Lact), 72.6 (C-2′Lact),
70.9 (C-3Pent), 70.6 (C-1Pent), 70.4 (C-4′Lact), 62.5 (C-6′Lact),
62.3 (C-6Lact), 53.2 (CH2N3), 46.8 (Cq), 31.3 (C-4Pent), 28.0
(C-5Pent). ESIMS: m/z 1378.4 [M + Na]+. Anal. Calcd for
C50H89N3O33S3: C, 44.27; H, 6.61; N, 3.10; S, 7.09. Found: C,
44.12; H, 6.56; N, 2.87; S, 6.73.
2.3. Tri-thiomannosyl and tri-thiolactosyl cluster conjugation
to NDs (respectively, ND-Man3 and ND-Lac3)
4-Pentynoic acid (0.20 mmol), DCC (0.22 mmol) and DMAP
(0.066 mmol) were dissolved in 5 mL anhydrous DMF. A sus-
pension of ND-OH particles in anhydrous DMF (10 mg in
5 mL) was added and the mixture stirred at room temperature
for 24 h under nitrogen. The alkynyl-terminated ND particles
(ND-alkynyl) were isolated through consecutive wash/centrifu-
gation cycles at 12 300 rcf with DMF (twice) and ethanol
(twice) and finally oven-dried at 50 °C overnight.
The ND-alkynyl (15 mg) were dispersed in 15 mL of anhy-
drous DMF and sonicated for 40 min. The “click” reaction was
carried out by addition of either Man3N3 (4 mM) or Lac3N3
and CuI(PPh3) (0.4 mM) to an ND-alkynyl suspension, followed
by stirring of both mixtures for 48 h at 80 °C. The resulting
reaction mixtures were each separated by centrifugation at
12 300 rcf, purified through consecutive wash/centrifugation
cycles at 12 300 rcf with DMF (twice) and 1 mM EDTA water
solution (twice), and finally oven-dried at 50 °C overnight.
2.4. Determination of the carbohydrate loading on particles
A calibration curve was established as described previously.40
An aqueous phenol solution (5 wt%, 60 µL) and concentrated
H2SO4 (900 µL) were added to an aqueous carbohydrate solu-
tion (60 µL), the mixture was stirred for 10 min and then an
absorption spectrum of the mixture was recorded (Perkin
Elmer Lambda 950 dual beam) against a blank sample
(reagent solutions without carbohydrate). The absorbance of
the solution was measured at two wavelengths: λ1 = 495 and λ2
= 570 nm and the absorbance diﬀerence (A495–A570) plotted
against the concentration of the corresponding monosacchar-
ide or disaccharide, respectively. Then, 60 µL of a selected
sugar-conjugated ND particle was suspended in water (0.8 mg
mL−1), and treated with phenol/H2SO4 and the protocol
described above was applied. The concentration of conjugated
sugar liberated was calculated with reference to the appropri-
ate calibration curve. Propargyl alcohol-terminated ND par-
ticles were subjected to identical treatment and used as a
blank sample.
2.5. Instrumentation
2.5.1. X-ray photoelectron spectroscopy. X-ray photo-
electron spectroscopy (XPS) measurements were performed
with an ESCALAB 220 XL spectrometer from vacuum genera-
tors featuring a monochromatic Al Kα X-ray source (1486.6 eV)
and a spherical energy analyzer operated in the CAE (constant
analyzer energy) mode (CAE = 100 eV for survey spectra and
CAE = 40 eV for high-resolution spectra), using the electro-
magnetic lens mode. The angle between the incident X-rays
and the analyzer is 58°. The detection angle of the photo-
electrons is 30°.
2.5.2. Particle size measurements. ND suspensions (20 µg
mL−1) in water were sonicated. The particle size of the ND sus-
pensions was measured at 25 °C using a Zetasizer Nano ZS
(Malvern Instruments S.A., Worcestershire, U.K.) in 173° scat-
tering geometry and the zeta potential was measured using the
electrophoretic mode.
2.5.3. NMR measurements. 1H (and 13C NMR) spectra
were recorded in a 500 (125.7 for 13C) MHz instrument. 2D
COSY, and 1H–13C HMQC experiments were used to assist
NMR assignments. See ESI† for spectra.
Electrospray mass spectra (ESIMS) were obtained for samples
dissolved in MeCN, MeOH, or H2O–MeOH mixtures at low μM
concentrations.
Elemental analyses were performed at the Instituto de
Investigaciones Químicas (Sevilla, Spain).
2.6. Biological assays
2.6.1. Bacterial cell strains and eukaryotic cells. GFP-
labeled E. coli constituvely expressing the type 1 fimbriae fim
operon under the control of λpR promoter (MG1655_λATT::
amp_GFP_kmPcL_fimAICDFGH) or deleted for the fim operon
(MG1655_λATT::amp_GFP_Δfim::cat )67 were grown in Lysogeny
Broth (LB) overnight at 37 °C at 200 rpm and diluted 1 : 100 to
M63B1 minimal media supplemented with 0.4% glucose
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(M63B1-Gluc) for another 24 h under static conditions at
37 °C. T24 human cell line derived from epithelial bladder cell
(ATCC HTB-4) were grown in McCoy’s 5A + Glutamax (Invitro-
gen) supplemented with 10% fetal bovine serum (FBS) and
maintained at 37 °C and 5% CO2. Cells were routinely split
twice a week at a 1 : 5 ratio.
2.6.2. Yeast agglutination assay. E. coli MG1655_λATT::
amp_GFP_kmPcL_fimAICDFGH or deletion mutant
MG1655_λATT::amp_GFP_Δfim::cat were grown in M63B1-Gluc
in static conditions, were washed with 1 volume of phosphate
saline buﬀer PBS 1× twice and diluted to optical density at
600 nm (OD600) of 1. Yeast grown in stationary phase in YPD
(Yeast extract Peptone-Dextrose) were washed twice and diluted
in PBS 1×. Each test compound was added to the bacteria
sample in the quantity required to reach the desired final con-
centration upon mixing with yeast and the mixture incubated
for 15 min at room temperature. Bacteria were then mixed
with yeast (OD600 nm 1 : 1) and placed in a 96-well microtiter
plate and agglutination was then assessed after 10 min
settling. The titer was considered as the lowest compound con-
centration that inhibits agglutination.
2.6.3. Inhibition of bacterial binding to T24 bladder
cells. T24 bladder cells were seeded per well into a 96-well
culture plates and incubated for 24 h under the same con-
ditions. Cell monolayer was washed three times with PBS before
adding bacteria. Static bacterial cultures grown in M63B1-Gluc
of the E. coli MG1655_λATT::amp_GFP_kmPcL_fimAICDFGH or
deletion mutant MG1655_λATT::amp_GFP_Δfim::cat were
washed three times with PBS and re-suspended in McCoy’s 5A
medium + Glutamax (Invitrogen) and vigorously vortexed in
order to disperse bacterial clumps. 100 µL of bacterial suspen-
sion were then added to the cell culture, centrifuged at 100
rpm for 5 min and incubated at 37 °C in 5% CO2. After 40 min
of incubation, cells were washed twice with PBS in order to
eliminate non-adherent bacteria. Attached bacteria were
released with Triton X-100 0.1% in PBS and transferred to a
Nunclon 96 flat bottom black plates and GFP fluorescence was
measured in Infinite 200 (Tecan) plate reader as a readout of
bacterial load. In order to establish the multiplicity of infec-
tion for each experiment, a bacterial suspension of 1.0 OD600
was serially diluted and used to test binding. The bacterial
OD600 used in the inhibition experiment corresponds to the
amount of bacteria that allows 50% of total binding to T24
cells. Each anti-adhesive compound was added at the desired
final concentration to a bacterial sample of predetermined
OD600 and the mixture incubated for 15 min at
room temperature before the binding assay. In all cases the
non-fimbriated isogenic strain MG1655_λATT::amp_GFP_Δ-
fim::cat was used as control. Experiments were performed in
triplicate, at least four times, from which the corresponding
IC50 values were computed. The levels of fluorescence
thus obtained were normalized to between 100%
(MG1655_λATT::amp_GFP_kmPcL_fimAICDFGH with no com-
pound) and 0% (MG1655_λATT::amp_GFP_Δfim::cat with
no compound). Statistical analysis was performed using
GraphPad Prism software.
2.6.4. Eukaryotic cell toxicity assay. T24 bladder cells were
incubated for 24 h with each of the ND particles, serially
diluted as indicated. Cell growth was determined by the MTT
reduction assay (Tox-1, Sigma Inc.). Experiments were per-
formed in triplicate at least three times. The activity in the
absence of NDs was taken as 100%.
2.6.5. Inhibition of biofilm formation in microtiter plates.
The inhibition of biofilm formation was assayed by determin-
ing the ability of the cells to adhere to the wells of 96-well non-
tissue culture-treated polyvinyl chloride (PVC) microtiter
dishes.68 Overnight cultures were adjusted to OD600 0.05 in
M63B1-Gluc medium. Compounds were serially diluted in
M63B1-Gluc medium. Equal volumes of bacteria and each
compound dilution were mixed, and 100 µL aliquots of each
mixture were added to a 96-well PVC plate. The plate was then
incubated at 37 °C for 24 h in a humid chamber. To detect
biofilm formation, wells were rinsed, and 125 µL of a 1% solu-
tion of crystal violet was added. The plates were then incu-
bated at room temperature for 15 min and again rinsed. The
crystal violet was completely dissolved by addition of 150 µL of
ethanol–acetone (80 : 20), and the OD595 of the resulting solu-
tion was measured. The reported data are averages of three
replicate wells in three independent experiments.
3. Results and discussion
3.1. Synthesis of trivalent sugar clusters for conjugation
Whereas conveniently functionalized peracetylated glycoden-
drons are often used as precursors for the generation of high-
valency sugar-coated systems, in our case the presence of pro-
gargyl ester groups at the surface of the alkyne-activated “click-
able” NDs prevents a post-coupling deacetylation step. Thus,
the alternative fully unprotected tri-α-mannopyranosyl Man3N3
and tri-β-lactosyl clusters Lac3N3, respectively, were required
(Fig. 2). Their synthesis has been carried out by implementing
a modular strategy that takes advantage of the radical addition
of thiols to double bonds (ene–thiol “click” coupling) for the
construction of glycodendrons.54 The ene–thiol addition pro-
ceeds with anti-Markovnikov regioselectivity and allows the
incorporation of thiosaccharidic motifs onto a polyene branch-
ing element. The resulting multivalent sugar cluster can be
further armed with an azido group for subsequent conjugation
purposes via Cu(I)-catalyzed azide–alkyne (CuAAC) coupling
reaction with suitable polyakyne partners. Readily accessible
triallylated pentaerythritol A was chosen as the central build-
ing block.64 The known per-O-acetyl-protected homo-trivalent
dendrons D62 and E63 were obtained using (i) UV light or azo-
bis(isobutironitrile) (AIBN)-initiated radical addition of either
the tetra-O-acetyl-α-D-mannopyranose or the hepta-O-acetyl-
β-lactose thiosugars B or C, respectively,65,66 to trialkene A, (ii)
subsequent triflyl activation of the focal primary hydroxyl in
the pentaerythritol scaﬀold and (iii) in situ azide anion dis-
placement of the thus formed triflate derivative. Conventional
catalytic deacetylation aﬀorded the target deprotected thio-
sugar clusters Man3N3 and Lac3N3, respectively (Fig. 2). The
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homogeneity and purity of all new structures were confirmed
by mass spectrometry, NMR spectroscopy and combustion
analysis. (See ESI† for NMR and HRMS spectra).
3.2. Fabrication of sugar cluster-conjugated nanodiamonds
The precursor tri-thiomannoside (Man3N3) and tri-thiolacto-
side (Lac3N3) clusters were conjugated to the ND nanoparticles
via a “click” strategy that diﬀered from the one described for
fabrication of our 1st-generation mannose-conjugated NDs
(Fig. 1).40 In the present work, hydroxyl-terminated ND
(ND-OH) was reacted with 4-pentynoic acid using N,N′-dicyclo-
hexylcarbodiimide (DCC) and a catalytic amount of 4-dimethy-
laminopyridine (DMAP) to give the corresponding ND-propargyl
(Fig. 1). The propargyl groups thus installed on the surface of
the NDs were then reacted with the appropriate azido-deriva-
tized tri-thioglycan partner (Man3N3 or Lac3N3), respectively, in
the presence of CuI(PPh3) as catalyst to give the corresponding
sugar cluster-clicked NDs. The successful coupling is in
addition confirmed by the presence of N1s and S 2p next to C
1s and O1s in the XPS survey spectrum (Table 1). The initial
ND-OH particles show 1.5 at% nitrogen presence most likely
generated during the detonation process where trinitrotoluene
is used. The level of N1s is increased in ND-Man3 and ND-Lac3
particles to 5.3 and 5.2 at%, respectively. The S/(N-1.5) ratio is
determined as 1.03 (ND-Man3) and 0.97 (ND-Lac3), close to the
theoretical value of 1. The amount of sugar clicked to a given
glyco-ND surface was quantified using a classical phenol-sulfu-
ric acid-based colorimetric method as has been reported pre-
viously.40 As expected (Table 1), the sugar loading is seen to be
almost three times higher for each of the ND-tri-thioglycan
clusters fabricated in this work than observed for the 1st-gene-
ration ND-sugar conjugates.40
3.3. Inhibition of type 1 fimbriae-mediated adhesion to
eukaryotic cells by mannose derivatives
Two independent assays were applied to evaluate the eﬃciency
of the tri-thiomannoside cluster-NDs to inhibit type 1 fim-
briae-mediated bacterial adhesion to eukaryotic surfaces: (i)
inhibition of yeast agglutination and (ii) inhibition of bacterial
adhesion on the T24 bladder cell line.
3.3.1. Yeast agglutination assay. The assay is based on
measuring the capacity of E. coli expressing type 1 fimbriae to
aggregate yeasts through bacterial recognition of mannosylated
residues present on their cell surface glycans and was per-
formed as previously described.40 The inhibition titer was
calculated as the minimum concentration of each sugar ana-
logue or ND derivative at which agglutination was blocked.
The data are summarized in Table 2. No inhibition of yeast
aggregation was detected with either the ND-OH or tri-thio-
lactoside cluster-modified ND ND-Lac3 controls. In contrast, all
compounds featuring mannosyl moieties were able to inhibit
the adhesion of bacteria to yeast cells to varying degrees. The
ND-Man3 particles give an inhibition titer of 3.14 μg mL−1
corresponding to a potency of 2970 relative to that of methyl
α-D-mannopyranoside (α-mmp), used as a monovalent refer-
ence. In comparison, a relative potency value of 1003 was
obtained with our 1st-generation mannose-functionalized NDs
in the same assay format.40 The unconjugated tri-thiomanno-
side cluster Man3N3 shows a potency of 32 relative to that of
α-mmp. Thus, the inhibitory potential of cluster Man3N3,
when conjugated to the ND particles, is 91 times more than
when unconjugated.
3.3.2. Bacterial binding to T24 bladder cell inhibition
assay. The new glyco-NDs were evaluated for their abilty to
interfere with FimH-mediated recognition by bacteria of T24
cells, a human bladder carcinoma cell line, following a pre-
viously described protocol40 (see Fig. 3). None of the new com-
pounds synthesized in this work exhibited any measurable
cytotoxicity towards T24 cells after 24 h of incubation at the
maximum concentrations employed in the assay (see ESI
Fig. S1†). As expected, neither the ND-OH, nor ND-Lac3
controls show any tendency to inhibit adherence to T24 cells
Table 1 Selected physical properties of the sugar-conjugated NDs
Diameter (nm) PIa
Zeta potential
(mV)
Sugar loading
(µg mg−1 ND) N 1s at% S 2p at%
ND-OH 89 ± 13 0.246 ± 0.002 35.3 ± 1.6 — 1.5 —
ND-alkynyl 126 ± 3 0.168 ± 0.021 34.2 ± 1.4 — 1.5 —
ND-Man3 125 ± 9 0.345 ± 0.003 27.2 ± 0.5 168 ± 12 5.3 3.9
ND-Lac3 138 ± 8 0.258 ± 0.062 31.2 ± 0.4 135 ± 18 5.2 3.6
a Polydispersity index; mean ± SD, n = 3.
Table 2 Inhibition of type 1 ﬁmbriae-mediated yeast agglutination
Compound
ITa
(μg mL−1)
RITb
(μM)
RIP50 (RIC50
α-mmp/RIC50
of the
compound)
RIP50 (RIC50
(Man3N3)/RIC50
of the
compound)
α-mmp — 7000 1
Man3N3 63.4 218.8 32
ND-Man3 3.14 2.4 2970 91
ND-Lac3 >100
c —
ND-OH >100 c —
ND-mannosed 19.4 6.98 1003
a IT = inhibition titre. b RIT = relative inhibition titre = IT × 3.45 µmol
mannose mg−1 for Man3N3 or 0.75 µmol mannose mg
−1 for ND-Man3
or 0.49 µmol lactose mg−1 for ND-Lac3, RIP50 = relative inhibition
potency of either α-mmp or Man3N3/RIC50 of the corresponding ND-
conjugate. All relative inhibition parameters are expressed as
micromolar concentration of carbohydrate. c Values not determined.
Sigmoïdal fitting of data not possible. d These parameters correspond
to those reported for 1st-generation mannose-NDs.40
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in this assay (Table 3). In contrast, the tri-thiomannoside
cluster Man3N3 was found to significantly aﬀect the adhesion,
exhibiting an inhibitory potency 229-fold higher than α-mmp
in this assay. The ND-Man3 displayed an inhibition potency of
30 502 relative to that of α-mmp (a value of 9259 is obtained
for our 1st-generation mannose-functionalized NDs in this
assay40). The activity of the tri-thiomannoside cluster Man3N3
is thus seen in this assay to be amplified some 133 times when
conjugated to the ND particles.
3.4. Inhibition of biofilm formation in microtiter plates
Type 1 fimbriae are well known to promote adhesion to abiotic
surfaces and to enhance biofilm formation. The initial attach-
ment and establishment of E. coli K-12 biofilms to abiotic
surfaces can be inhibited by α-mannopyranosyl containing
O-glycosides and O-glycans, implicating the integral role of the
FimH lectin in this process.69 The biofilm disrupting ability of
the various sugar ligands and conjugated-nanostructures fabri-
cated in this work was evaluated, as previously described,
using an assay that measures their ability to inhibit E. coli
MG1655_λATT::amp_GFP_kmPcL_fimAICDFGH biofilm for-
mation on polyvinyl chloride (PVC) surfaces (Fig. 4).40 Whereas
neither the ND-OH nor ND-Lac3 controls proved active (data
not shown), both the unconjugated tri-thiomannoside cluster
Man3N3 and ND-Man3 displayed a strong disrupting eﬀect on
biofilm formation as compared to α-mmp.
The biofilm inhibitory potency of the ND-Man3 described
herein is significantly greater than that observed for our 1st
generation sugar-NDs (ca. 10 fold).40 However, the relatively
small increase in the biofilm inhibition potency of ND-Man3N3
relative to that of the Man3N3 (a factor of 2) is in sharp contrast
to the large increases in adhesion inhibition observed upon
conjugation of Man3N3 to NDs in the corresponding yeast
agglutination and T24 bladder cells binding assays and
perhaps deserves comment. Adhesion of bacteria to bladder
cells and yeast agglutination are exclusively dependent on type
1 fimbriae, whereas biofilm formation by E. coli cells is known
to be mediated not only by type 1 fimbriae but also through
the interplay of number of additional cell surface appendages.
Additionally biofilms are constituted of a complex matrix of
high molecular weight constituents including polysaccharides
and this would be expected to impede diﬀusion of large mole-
cules such as NDs conjugates relative to that of smaller
entities.
4. Conclusions
In this work we demonstrate that sugar-conjugated nano-
diamonds have marked detrimental eﬀects on E. coli-mediated
biofilm formation and that this phenomenon is related to
their ability to interfere with FimH-mediated bacterial
adhesion. The conjugation strategy developed for these 2nd-
generation sugar conjugated NDs, using alkynyl-functionalized
NDs, proves as eﬃcient as the one described previously which
was based on azido-functionalized NDs.40 Having in hand this
pair of complementary strategies for surface modification of
ND particles, makes possible the application of the Huisgen
Cu(I) “click” methodology to a wide range of propargyl- or
azido-armed ligand counterparts thus greatly broadening its
scope. The demonstration that the tri-thiomannoside cluster-
NDs (ND-Man3) fabricated here are able to eﬀectively impede
type 1 fimbriae-mediated bacterial adhesion in two indepen-
Fig. 3 Inhibitory eﬀects of mannosylated compounds on type 1
ﬁmbriae-mediated adhesion to T24 bladder epithelial cells. E. coli
MG1655_λATT::amp_GFP_kmPcL_ﬁmAICDFGH or deletion mutant
MG1655_λATT::amp_GFP_Δﬁm::cat were mixed with the various com-
pounds individually added and incubated with T24 bladder cells for
40 min. After washing, adhesion was evaluated by measurements of gfp
ﬂuorescence using a Tecan Sunrise™ multiwell plate reader and
expressed as relative ﬂuorescence units (R.F.U.). The ﬂuorescence values
thus obtained were normalized to between 100% (MG1655_λATT::
amp_GFP_kmPcL_ﬁmAICDFGH with no compound) and 0%
(MG1655_λATT::amp_GFP_Δﬁm::cat with no compound). Data are
expressed as the percentage of bacteria adhered with respect to that in
the absence of compound. Experiments were performed in triplicate at
least twice. Determination of IC50 values were performed with GraphPad
Prism software (GraphPad Inc.). Sigmoïdal ﬁtting curves of the log of
relative inhibitory concentration 50 (RIC50) are represented for α-mmp,
tri-thiomannoside cluster, Man3N3 and ND-Man3.
Table 3 Inhibition of type 1 ﬁmbriae mediated adhesion to T24 bladder
cells
Compound
IC50
(μg mL−1)
RIC50
a
(μM)
RIP50 (RIC50
α-mmp/RIC50
of the
compound)
RIP50 (RIC50
(Man3N3)/RIC50
of the
compound)
α-mmp — 22 511 1
Man3N3 28.5 98.2 229
ND-Man3 0.98 0.738 30 502 133
ND-Lac3 >100
b
ND-OH >100 b
ND-mannosec 7.6 2.7 9259
a RIC50 = relative IC50 = IC50 × 3.45 µmol mannose mg
−1 for Man3N3 or
0.75 µmol mannose mg−1 for ND-Man3 or 0.49 µmol lactose mg
−1 for
ND-Lac3, RIP50 = relative inhibition potency of α-mmp or Man3N3/
RIC50 of the compound. All relative inhibition parameters are
expressed as micromolar concentration of carbohydrate. b Values not
determined. Sigmoïdal fitting of data not possible. c These parameters
correspond to those reported for 1st-generation mannose-NDs.40
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dent assay formats is consistent with our earlier findings that
mannose-conjugated NDs have a marked E. coli anti-adhesive
activity.
The ability of the new glycocluster-NDs to significantly
inhibit E. coli-mediated biofilm formation is remarkable. The
fact that both the 1st-(glycoside) and 2nd-(thioglycoside) gener-
ations of glyco-NDs both manifest this property is also
notable.40 Moreover, the finding that the unconjugated tri-
meric thiomannoside cluster Man3N3 shows a non-negligible
activity as a biofilm inhibitor, despite its low relative molecular
weight was unexpected. Indeed, rarely have sugar-based inhibi-
tors of E. coli-generated biofilms been reported although a
number have for biofilms mediated by Pseudomonas aerugi-
nosa.70,71 The fact that Man3N3 does not feature any triazole
segment in the vicinity of the sugar moiety strongly suggests
that the presence of the heterocycle as an integral feature of
the 1st-generation NDs is not critical for their ability to inhibit
biofilm formation. In addition, neither the ND-OH nor
ND-Lac3 controls are seen to show any anti-adhesive activity,
underlining that the activities observed for the thiomannosyl
conjugates are sugar-specific. Taken together, the data sup-
ports that it is the presence of mannosyl residues in the thio-
sugar clusters that constitute the primary ingredient driving
the biofilm-inhibitory activity observed for the ND-conjugates:
neither the presence of triazole functions or the interplay of
some intrinsic physico-chemical property of the nanodiamond
core itself have an obvious influence on this process.
Although it would be premature to advance a detailed expla-
nation for this observation at this point, such biofilm inhi-
bition eﬀects would constitute a useful additional feature of
any anti-adhesive lead and has rarely been reported in the past
for the alternative mono- or multivalent-mannose derivatives.
We suspect that the activities brought to light in this work
might not be exclusive to nanodiamond-based sugar conju-
gates. Moreover, the finding that the tri-thiomannosyl cluster
Man3N3 itself is a relatively eﬃcient inhibitor, even when not
conjugated to any ND scaﬀold, suggests that alternative mono-
and medium- to low-valency mannosyl conjugates might also
demonstrate significant E. coli-mediated biofilm disrupting
properties, a hypothesis that deserves to be further investi-
gated.
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